Clinical Trial Update: Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating 24-hour glucose control with saxagliptin added to metformin XR vs uptitrated metformin XR in adults with type 2 diabetes; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucophage XR (metformin hydrochloride extended-release)
• Onglyza (Saxagliptin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2011-10-06